Danisco A/S

Danisco A/S

Copenhagen Denmark
Is it you?
Investor info
Stage focus
  • Early stage VC,
  • Later stage VC
Industry focus
Description
Danisco A/S produces and sells food ingredients and industrial bioproducts primarily in Europe, North America, Latin America, and the Asia Pacific. The company's Emulsifiers division supplies food emulsifiers; and GRINDSTED SOFT-N-SAFE, a vegetable-based plasticizer for the plastic industry. Its Gums and Systems division offers textural ingredients based on a portfolio of hydrocolloids and functional systems. It produces six types of hydrocolloids that are manufactured from selected natural raw materials, such as seaweed, citrus fruits, locust bean, and guar seeds. This division serves the food, cosmetics, paper, textiles, and pharmaceuticals industries. The company's Sweeteners division supplies specialty sweeteners and related ingredients for use in food, pharmaceuticals, sports nutrition, and oral hygiene products. It offers sweeteners, including xylitol, fructose, and Litesse polydextrose that are used to reduce the risk of lifestyle diseases, such as obesity, diabetes, and tooth decay. Its Cultures division produces cultures and media to the dairy, meat, and health industries. It offers probiotic cultures to stimulate gut health and enhance the immune system in food, dietary supplements, and beverages. This division also supplies natural food protection solutions, such as antioxidants and antimicrobials; and enzymes for cheese production. The company's Genencor division discovers, develops, and manufactures enzymes and bio-based solutions for the animal nutrition, biodefense, biosafety, carbohydrate processing, food and beverages, fuel ethanol, laundry detergents, and textile industries. It produces second generation bioethanol from non-food raw materials. Danisco was founded in 1989 and is headquartered in Copenhagen K, Denmark.
Relevant investments
  • Company
    Amount
    Round
  • Example example company Inc
    $ 1,000,000
    Investor meetings
  • Company & Company
    € 11,000,000
    Series C funding
  • Example
    $ 524,000
    Seed round A
Show more
Connected people
Email visible after logging in
  • Example Example
    Example Exampleexample[email protected]
  • Example Exampleexample
    Example Exampleexample
  • Notexample Examplenot
    Notexample Examplenotexample example[email protected]
  • Example Examplenotexample
    Example Examplenotexampleexample example[email protected]
  • Example Example
    Example Exampleexample[email protected]
  • Example Example
    Example Exampleexample[email protected]
Show more
X Feed
See other investors focused on
Biotechnology
Made with in San Francisco, Valencia, Oslo, Cherkasy and Warsaw© 2015-     Foundersuite, Inc.